Dziegielewski, C.
Fernando, SM.
Milani, C.
Mahdavi, R.
Talarico, R.
Thompson, LH.
Tanuseputro, P.
Kyeremanteng, K.
Article History
Received: 12 November 2022
Accepted: 30 September 2023
First Online: 19 October 2023
Declarations
:
: The study design and methodology were carried out in accordance with ICES guidelines and regulations, and received ethics approval from the Research Ethics Board at Sunnybrook Health Sciences Centre, Toronto, Canada. The use of data in this project was authorized under Sect. 45 of Ontario’s Personal Health Information Protection Act, which does not require review by a Research Ethics Board. All experimental protocols related to this study, as well as access of study data, were approved by ICES. ICES is a prescribed entity under Ontario’s Personal Health Information Protection Act (PHIPA). Section 45 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system. Projects that use data collected by ICES under Sect. 45 of PHIPA, and use no other data, are exempt from REB review. The use of the data in this project is authorized under Sect. 45 and approved by ICES’ Privacy and Legal Office. Study data was anonymized before its use.
: Not applicable.
: The authors declare that they have no competing interests.